Thanks to this Professional master’s degree you will obtain in only 12 months the most advanced update in diagnostic and therapeutic procedures in Oncological Ophthalmology"

In recent years, there has been notable progress in the performance of specific diagnostic tests that allow the ophthalmologist to perform an in-depth study of the anatomical and functional status. In addition, thanks to new pharmacological, physical or surgical therapies, treatments have been improved with a hopeful prognosis for the patient.

In this scenario, the professionals who wishes to be updated in the advances in this field will be able to do it through this university program designed by TECH. A program that will take the specialist to a complete update of their knowledge in Oncological Ophthalmology over 12 months.

It is an intensive program that delves from the first moment in Ocular  Oncology, the most important radiological characteristics of intraocular and orbital tumor pathology, the main tumors of the eyeball and orbit, with special emphasis on the two most relevant malignant neoplasms of the eye: Uveal Melanoma and Retinoblastoma. In addition, this program goes a step further and offers the graduates a module oriented to the approach of the patient from the psychiatric and psychological aspect, which completes an already exhaustive syllabus in Ocular Tumors.

To achieve this goal of updating, students have access to video summaries of each topic, specialized readings or scenarios of simulated case studies that can be accessed comfortably from a digital device at any time of the day. Likewise, the Relearning system, based on the reiteration of content, will lead the professionals to progress naturally through the main concepts of this program and thus reduce the long hours of study.

A Professional master’s degree that provides the flexibility that the ophthalmologists require to make their daily work and personal activities compatible with a quality program, developed by an excellent team of specialists with a high level of competence in this field.

Get the most detailed information on the most sophisticated tumor radiobiology techniques used today"

This Professional master’s degree in Oncological Ophthalmology contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Oncological Ophthalmology
• Graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

An academic option that will lead you to implement the best strategies to address both systemic and locally advanced or unresectable diseases"

The program includes in its teaching staff professionals from the sector who pour into this training the experience of their work, in addition to recognized specialists from reference societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will provide the professionals with situated and contextual learning, i.e., a simulated environment that will provide an immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby professionals must try to solve the different professional practice situations that arise throughout the program. For this purpose, the students will be assisted by an innovative interactive video system created by renowned experts.

TECH adapts to your schedule and has designed a flexible problem that is compatible with your professional responsibilities"

A university qualification that will allow you to delve into the management of the main systemic treatment options for metastatic ocular tumors"

The syllabus of this university program has been designed to offer in only 12 months, the most rigorous and exhaustive information on Oncological Ophthalmology. All this, agglutinated in a syllabus prepared by real specialists in this field and with quality teaching materials. Thus, the graduates will be able to update on Ocular Oncology and the advances in diagnostic techniques and treatments to deal with the most frequent tumors in young and adult patients.

A syllabus made up of an extensive Virtual Library, accessible 24 hours a day, from any digital device with Internet connection"

Module 1. Ocular Oncology

1.1. Epidemiological Aspects of Ocular Tumors

1.1.1. Definition of Neoplasms
1.1.2. Risk Factors
1.1.3. Epidemiology

1.2. Classification of Ocular Neoplasms

1.2.1. According to Main Location
1.2.2. According to Histological Subtype
1.2.3. According to Age

1.3. Tumorogenesis

1.3.1. Etiology of Cancer
1.3.2. Immunology
1.3.3. Genetics

1.4. Complementary Tests I

1.4.1. Anterior Pole Imaging
1.4.2. Retinography
1.4.3. Wide Field Imaging

1.5. Complementary Tests II

1.5.1. Fluorescein Angiography
1.5.2. Indocyanine Green Angiography
1.5.3. Autofluorescence

1.6. Complementary Tests III: Optical Coherence Tomography (OCT)

1.6.1. Anterior Pole OCT
1.6.2. Posterior Pole OCT
1.6.3. Angio-OCT

1.7. Complementary Tests IV: Ultrasound

1.7.1. Ultrasonic Biomicroscopy (BMU)
1.7.2. Ocular Ultrasonography
1.7.3. Doppler Ultrasound

1.8. Complementary Tests V: Orbit and Extension Study

1.8.1. Computerized Axial Tomography (CAT)
1.8.2. Positron Emission Tomography (PET) - CT Scan
1.8.3. Magnetic Resonance Imaging (MRI)

1.9. Biopsies in Ocular Oncology

1.9.1. Criteria for Taking Biopsies
1.9.2. Technique in Orbit and Ocular Surface Neoplasms
1.9.3. Technique in Intraocular Neoplasms

1.10. Treatments Used in Ocular Oncology

1.10.1. Chemotherapy
1.10.2. Radiotherapy
1.10.3. Surgical Treatments

Module 2. Palpebral, Tear Duct and Orbital Tumors

2.1. Benign Palpebral Tumors

2.1.1. Classification
2.1.2. Epidemiology
2.1.3. Clinicopathological Characteristics

2.2. Premalignant Palpebral Tumors

2.2.1. Classification
2.2.2. Epidemiology
2.2.3. Clinicopathological Characteristics

2.3. Malign Palpebral Tumors

2.3.1. Classification
2.3.2. Epidemiology
2.3.3. Clinicopathological Characteristics

2.4. Palpebral Lesions Simulating Neoplasia

2.4.1. Classification
2.4.2. Epidemiology
2.4.3. Clinicopathological Characteristics

2.5. Medical-surgical Management of Palpebral Tumors

2.5.1. Medical Treatment
2.5.2. Surgical treatment
2.5.3. Complications

2.6. Tear Drainage System Tumors

2.6.1. Benign Tumors
2.6.2. Malignant Tumors
2.6.3. Medical- Surgical Management

2.7. Benign Orbital Tumors

2.7.1. Classification
2.7.2. Epidemiology
2.7.3. Clinicopathological Characteristics

2.8. Malign Orbital Tumors

2.8.1. Classification
2.8.2. Epidemiology
2.8.3. Clinicopathological Characteristics

2.9. Orbital Lesions Simulating Neoplasia

2.9.1. Classification
2.9.2. Epidemiology
2.9.3. Clinicopathological Characteristics

2.10. Medical-surgical Management of orbital Tumors

2.10.1. Medical Treatment
2.10.2. Surgical treatment
2.10.3. Complications

Module 3. Tumors of Ocular Surface and Cornea

3.1. Anatomy

3.1.1. Anatomy of the Conjunctiva
3.1.2. Vascularization
3.1.3. Innervation

3.2. Non-pigmented Tumors I

3.2.1. Squamous Neoplasm of the Ocular Surface (SNOS)
3.2.2. Lymphoid Hyperplasia
3.2.3. Lymphomas

3.3. Non-pigmented Tumors II

3.3.1. Dermoid Cysts
3.3.2. Papillomas
3.3.3. Pyogenic Granuloma

3.4. Pigmented Tumors I

3.4.1. Nevi
3.4.2. Racial Melanocytosis
3.4.3. Primary Acquired Melanocytosis

3.5. Pigmented Tumors II

3.5.1. Secondary Acquired Melanocytosis
3.5.2. Melanoma
3.5.3. Simulating Injuries

3.6. Diagnosis I

3.6.1. Slit Lamp Examination
3.6.2. Impression Cytology
3.6.3. Anterior Segment OCT

3.7. Diagnosis II

3.7.1. Angio-OCT
3.7.2. Confocal Microscopy
3.7.3. BMU

3.8. Medical Treatment

3.8.1. Mitomycin C Eyedrops
3.8.2. 5-fluorouracil Eyedrops
3.8.3. Interferon Eyedrops

3.9. Surgical treatment

3.9.1. Biopsy / non touch technique
3.9.2. Indications
3.9.3. Contraindications

3.10. Prognosis

3.10.1. Complications
3.10.2. Recurrence
3.10.3. Survival

Module 4. Intraocular Tumors in Adults

4.1. Pigmented Non-tumorous Lesions of the Ocular Fundus

4.1.1. Congenital Hypertrophy of the Retinal Pigment Epithelium
4.1.2. Acquired Hypertrophy of the Retinal Pigment Epithelium
4.1.3. Hyperplasia of the Retinal Pigment Epithelium

4.2. Pigmented Lesions of the Fundus

4.2.1. Choroidal Nevus
4.2.2. Melanocytoma
4.2.3. Combined Hamartoma of the Retina and Retinal Pigment Epithelium
4.2.4. Simple Congenital Hamartoma of the Retinal Pigment Epithelium

4.3. Suspicious Choroidal Nevus vs. Small Choroidal Melanoma 

4.3.1. Definition
4.3.2. Risk Factors for Transformation
4.3.3. Treatment

4.4. Choroidal Melanoma

4.4.1. Epidemiology
4.4.2. Risk Factors
4.4.3. Prognostic Biomarkers
4.4.4. Diagnostic Techniques

4.5. Choroidal Melanoma: Treatment

4.5.1. Brachytherapy and Radiation Retinopathy
4.5.2. Endoresection
4.5.3. Enucleation

4.6. Melanoma of the Iris and Ciliary Body

4.6.1. Diagnostic Techniques: BMU
4.6.2. Differential Diagnosis
4.6.3. Treatment

4.7. Intraocular Lymphoma

4.7.1. Primary Vitreoretinal Lymphoma
4.7.2. Primary Uveal Lymphoma and Primary Choroidal Lymphoma
4.7.3. Secondary Choroidal Lymphoma

4.8. Choroidal Vascular Tumors

4.8.1. Diffuse Choroidal Hemangioma and Sturge-Weber Syndrome
4.8.2. Circumscribed Choroidal Hemangioma
4.8.3. Treatment of Circumscribed Choroidal Hemangioma

4.9. Retinal Vascular Tumors

4.9.1. Hemangioblastoma or Retinal Capillary Hemangioma
4.9.2. Retinal Cavernous Hemangioma
4.9.3. Racemose Hemangioma or Arterio-venous Malformations
4.9.4. Vasoproliferative Tumor
4.10. Non-pigmented Choroidal tumors
4.10.1. Choroidal Osteoma
4.10.2. Choroidal Metastasis

Module 5. Retinoblastoma

5.1. Epidemiology

5.1.1. Introduction
5.1.2. Incidence
5.1.3. Prevalence
5.1.4. Predisposing Factors

5.2. Genetics

5.2.1. Rb Gene
5.2.2. Genetic Presentations
5.2.3. Genetic Tests
5.2.4. Genetic Counseling

5.3. Clinical Symptoms

5.3.1. Symptoms and Signs
5.3.2. Growth Patterns
5.3.3. Intraocular Seedings

5.4. Extraocular Involvement

5.4.1. Trilateral Retinoblastoma
5.4.2. Metastatic Retinoblastoma
5.4.3. Second Tumors

5.5. Diagnosis

5.5.1. Clinical Examination
5.5.2. Complementary Tests
5.5.3. Systemic Evaluation and Nuclear Magnetic Resonance Imaging (MRI)
5.5.4. Differential Diagnosis
5.5.5. Classification

5.6. Treatment.I: Chemoreduction

5.6.1. Treatment Objectives
5.6.2. Systemic Chemotherapy
5.6.3. Intra-arterial Chemotherapy
5.6.4. Other Chemotherapy Modalities

5.7. Treatment II: Consolidation and Enucleation

5.7.1. Cryotherapy, Hyperthermia and Photocoagulation
5.7.2. Brachytherapy
5.7.3. Enucleation

5.8. Therapeutic Response and Follow-up

5.8.1. Patterns of Tumor Regression
5.8.2. Ophthalmologic Follow-up
5.8.3. Oncologic Follow-up

5.9. Complications

5.9.1. Complications Derived from Systemic Treatment
5.9.2. Complications Derived from the Ocular Treatment
5.9.3. Other complications

5.10. Visual Development of the Child with Retinoblastoma

5.10.1. Evaluation of the Visual Function of a Child with Retinoblastoma at Diagnosis
5.10.2. Sensory and Motor Exploration
5.10.3. Ophthalmologic Management

Module 6. Radiology Applied to Ocular Oncology

6.1. Radiology in Ocular Oncology

6.1.1. Technical Considerations
6.1.2. Indications
6.1.3. Protocols

6.2. Benign Intraocular Tumors

6.2.1. Choroid-retinal Hemangiomas
6.2.2. Retinal Melanocytoma
6.2.3. Others

6.3. Malignant Intraocular Tumors I: Retinoblastoma

6.3.1. Introduction
6.3.2. Imaging Tests
6.3.3. Radiological Differential Diagnosis: Coats disease, persistent hyperplastic primary vitreous, retinopathy of prematurity

6.4. Malignant Intraocular Tumors II: Uveal Melanoma

6.4.1. Introduction
6.4.2. Imaging Tests
6.4.3. Clinical- Radiological Correlation

6.5. Malignant Intraocular Tumors III: Metastasis

6.5.1. Introduction
6.5.2. Imaging Tests
6.5.3. Clinical- Radiological Correlation

6.6. Benign Orbital Tumors I

6.6.1. Child Hemangioma
6.6.2. Optic Tract Glioma
6.6.3. Optic Nerve Sheath Meningioma

6.7. Benign Orbital Tumors II

6.7.1. Pleomorphic Adenoma or Mixed Tumor of the Lacrimal Gland
6.7.2. Dermoid Cysts
6.7.3. Lipoma

6.8. Malign Orbital Tumors I

6.8.1. Metastasis
6.8.2. Lymphoproliferative Lesions
6.8.3. Rhabdomyosarcoma

6.9. Malign Orbital Tumors II

6.9.1. Lacrimal Gland Carcinomas
6.9.2. Plasma Cell Tumors
6.9.3. Others

6.10. Other Orbital Tumor Pathology for Differential Diagnosis

6.10.1. Lymphatic Malformations: lymphagioma
6.10.2. Arteriovenous Malformations
6.10.3. Idiopathic Orbital Inflammatory Disease or Inflammatory Pseudotumor of the Orbit

Module 7. Pathological Anatomy Applied to Ocular Oncology

7.1. Anatomy and Histology of the Eye

7.1.1. Eye Anatomy
7.1.2. Histology of the Eye

7.2. Tumors of the Ocular Orbit

7.2.1. Pediatric Tumors of the Orbit
7.2.2. Benign Tumors of the Orbit
7.2.3. Malignant Tumors of the Orbit

7.3. Conjunctival and Corneal Tumors

7.3.1. Epithelial Tumors
7.3.2. Melanocytic Tumors
7.3.3. Other tumours

7.4. Tumors of the Uvea (non-melanoma)

7.4.1. Benign Melanocytes tumors
7.4.2. Epithelial Tumors
7.4.3. Other tumours

7.5. Uveal Melanoma

7.5.1. Epidemiology
7.5.2. Histopathology
7.5.3. Molecular Aspects

7.6. Neurosensory Retinal Tumors

7.6.1. Retinoblastoma
7.6.2. Astrocytoma
7.6.3. Vitreoretinal Lymphoma

7.7. Retinal Epithelial Tumors

7.7.1. Benign Tumors
7.7.2. Malignant Tumors

7.8. Optic Disc and Optic Nerve Tumors

7.8.1. Primary Tumors
7.8.2. Secondary Tumors

7.9. Lacrimal Gland Tumors

7.9.1. Epithelial Tumors
7.9.2. Hematolymphoid Tumors
7.9.3. Secondary Tumors
7.10. Tear Drainage System Tumors
7.10.1. Epithelial Tumors
7.10.2. Other tumours

Module 8. Medical Oncology Applied to Ocular Oncology

8.1. Systemic Treatment in Ocular Tumors

8.1.1. Introduction
8.1.2. Chemotherapy Mechanism of Action
8.1.3. Mechanism of Action of Immunotherapy and Other Targeted Therapies

8.2. Localized Uveal Melanoma

8.2.1. Adjuvant Systemic Treatment
8.2.2. New Molecules
8.2.3. Monitoring

8.3. Metastatic Uveal Melanoma I

8.3.1. Chemoembolization of Hepatic Metastases
8.3.2. Radiofrequency
8.3.3. Other Local Techniques

8.4. Metastatic Uveal Melanoma II

8.4.1. Immunotherapy
8.4.2. Chemotherapy
8.4.3. New Drugs

8.5. Ocular Lymphoma

8.5.1. General Treatment Indications
8.5.2. Chemotherapy
8.5.3. Others

8.6. Palpebral Carcinomas

8.6.1. Basal Cell Carcinoma
8.6.2. Squamous Cell Carcinoma
8.6.3. Others

8.7. Conjunctival Melanoma

8.7.1. Diagnosis
8.7.2. Treatment
8.7.3. Monitoring

8.8. Ocular Toxicity Associated with Oncological Treatment

8.8.1. Anti- EGFR Drugs
8.8.2. BRAF and MEK Inhibitors
8.8.3. Immuno-checkpoints

8.9. Ocular Metastases

8.9.1. General Aspects
8.9.2. Breast Cancer
8.9.3. Cancer Lung and Others

8.10. Ocular Tumors Associated with Hereditary Syndromes

8.10.1. General Considerations
8.10.2. Neurofibromatosis
8.10.3. Others

Module 9. Radiation Oncology Applied to Ocular Oncology

9.1. Radiobiology

9.1.1. Biological Radiation Injury
9.1.2. Molecular Mechanisms
9.1.3. The "5 R's" of Radiotherapy

9.2. Radiophysics I

9.2.1. Magnitudes and Units of Measurement
9.2.2. Interaction of Radiation with Matter
9.2.3. External Radiotherapy Beams and Encapsulated Sources

9.3. Radiophysics II

9.3.1. Dosimetry of Beams and Sources: Quality Control
9.3.2. Treatment Design
9.3.3. Treatment Volumes and Organs at Risk

9.4. Radiophysics III

9.4.1. Radiation Protection: General Principles
9.4.2. Regulations and Legislation
9.4.3. Operational Radiation Protection

9.5. Special Treatment Techniques: Brachytherapy

9.5.1. Fundamentals
9.5.2. Methodology
9.5.3. General Treatment Indications

9.6. Uveal Melanoma

9.6.1. Diagnosis
9.6.2. Treatment
9.6.3. Monitoring

9.7. Ocular Lymphoma

9.7.1. Diagnosis
9.7.2. Treatment
9.7.3. Monitoring

9.8. Retinoblastoma

9.8.1. Diagnosis
9.8.2. Treatment
9.8.3. Monitoring

9.9. Ocular Metastases

9.9.1. General Aspects
9.9.2. Breast Cancer
9.9.3. Lung Cancer

9.10. Benign Pathology

9.10.1. Local Therapies: general
9.10.2. Thyroid Ophthalmopathy or Graves' Orbitopathy
9.10.3. Hemangiomas

Module 10. Psychiatric and Psychological Aspects of Ocular Oncology

10.1. Psychological Responses to Cancer Illness

10.1.1. Stress Factors
10.1.2. Types of Personality
10.1.3. Coping Styles

10.2. Emotional Responses to Cancer Illness

10.2.1. Anxiety and Fear
10.2.2. Sadness and Guilt
10.2.3. Feeling of Shame

10.3. Mental Disorder in Cancer Patients

10.3.1. Depression
10.3.2. Anxiety
10.3.3. Suicidal Behavior

10.4. Psychological Approach

10.4.1. Types
10.4.2. Patients
10.4.3. Family and Environment Social

10.5. Psychopharmacological treatment

10.5.1. Depression
10.5.2. Anxiety
10.5.3. Delirium

10.6. Key Aspects of Teamwork for Comprehensive Care

10.6.1. Professional Care
10.6.2. Accompaniment
10.6.3. Importance of Nursing Personnel

10.7. Interpersonal Communication in Oncological Processes

10.7.1. Professional Skills
10.7.2. How to give bad news
10.7.3. Patient Autonomy

10.8. Specific Aspects in Children and Adolescents

10.8.1. Information
10.8.2. Coping
10.8.3. Family Approach

10.9. Maladaptive Behavior in Oncology Patients

10.9.1. Therapeutic Non-compliance
10.9.2. Psychological Factors
10.9.3. Interventions

10.10. Psychological Intervention in Patients With Ocular Enucleation

10.10.1. Grief
10.10.2. Individual Intervention
10.10.3. Family Approach

Get a complete update on the latest advances in Radiation Oncology applied to Ocular Oncology"